Cleerly LABS vs Mindbowser AI Cardiovascular Risk Prediction
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your primary need is a detailed, AI-powered quantitative and qualitative analysis of coronary CT angiography (CCTA) images. This tool is ideal for precisely detecting, quantifying, and characterizing atherosclerosis and stenosis to guide personalized heart disease management and track disease progression over time, providing critical visual and volumetric data.
View Cleerly LABS →Choose Mindbowser AI Cardiovascular Risk Prediction if…
Choose Mindbowser AI Cardiovascular Risk Prediction if you require an integrated, AI-powered solution for broad cardiovascular risk assessment directly within your existing EHR systems. This tool is best suited for identifying at-risk patients in a general clinical setting, supporting preventative care, and leveraging clinical data for decision support without requiring specialized imaging.
View Mindbowser AI Cardiovascular Risk Prediction →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | Mindbowser AI Cardiovascular Risk Prediction |
|---|---|---|
| Pricing | Varies | Contact for pricing |
| Deployment | Cloud, On-premise | Cloud-based |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Unknown |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cleerly LABSCleerly LABS is described as a 'web-based software' with '3D visualization of coronary arteries,' suggesting a dedicated and interactive user interface for detailed image analysis. While Mindbowser emphasizes EHR integration, Cleerly's explicit features point to a potentially richer and more specialized user experience for its core function of CCTA analysis.
Clinical Value
Cleerly LABSCleerly LABS holds FDA clearance for its comprehensive CCTA analysis, enabling the detection, quantification, and characterization of atherosclerosis and stenosis, directly aiding in personalized heart disease management and tracking progression. Mindbowser's tool offers 'AI Cardiovascular Risk Prediction' and 'Clinical Decision Support,' which are valuable but less specific and lack the explicit regulatory validation and detailed diagnostic capabilities of Cleerly's offering.
Pricing & Value
Cleerly LABSCleerly LABS provides transparent pricing information, including a per-analysis cost and details on potential out-of-pocket expenses, allowing for a clearer assessment of its value proposition. Mindbowser's 'contact for pricing' approach offers no immediate transparency, making it impossible to evaluate its cost-effectiveness without further inquiry.
Enterprise Readiness
Mindbowser AI Cardiovascular Risk PredictionBoth tools demonstrate strong enterprise readiness with cloud deployment, HIPAA compliance, and EHR integration. However, Mindbowser explicitly mentions SOC 2 compliance and specific integrations with major EHR systems like Epic, Cerner, Athenahealth, and adherence to HL7 & FHIR interoperability standards, which are critical for seamless adoption in diverse healthcare enterprise environments.
Innovation
Cleerly LABSCleerly LABS showcases a higher degree of specialized innovation by applying AI to CCTA for detailed, quantitative plaque assessment and characterization, aiming to establish a 'new standard of care to eliminate heart attacks.' Mindbowser's 'AI Cardiovascular Risk Prediction' is innovative, but Cleerly's focus on advanced imaging diagnostics for precise disease characterization represents a more distinct advancement in the field.
Support & Docs
TieNeither the provided structured facts nor readily available public web searches offer specific details regarding the support channels or documentation available for either Cleerly LABS or Mindbowser AI Cardiovascular Risk Prediction. Without this information, it is not possible to differentiate between the two tools on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | Mindbowser AI Cardiovascular Risk Prediction |
|---|---|---|
| Name | Cleerly LABS | Mindbowser AI Cardiovascular Risk Prediction |
| Company | Cleerly | Mindbowser |
| Description | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | Part of their comprehensive suite of healthcare AI solutions, designed for providers and hospitals to assess cardiovascular risks. It emphasizes compliance with HIPAA and SOC 2 and integrates with leading EHR systems. |
| Key Features | AI-powered CCTA image analysis, Comprehensive coronary plaque assessment (volume, type), Stenosis detection and quantification, Ischemia detection (with Cleerly ISCHEMIA module), 3D visualization of coronary arteries, Personalized heart disease risk assessment, Tracking disease progression over time, Integration with PACS, RIS, EHR via Cleerly Proxy | AI Cardiovascular Risk Prediction, AI-powered automation, HIPAA and SOC 2 compliance, EHR integration (Epic, Cerner, Athenahealth, FHIR), Clinical Decision Support System, Data & Analytics, HL7 & FHIR interoperability, Secure, compliant healthcare data access |
| Specialties | Cardiology, Radiology | Cardiology, Family Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and Mindbowser AI Cardiovascular Risk Prediction.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or Mindbowser AI Cardiovascular Risk Prediction
Backers
Who funded each tool's parent company.